Product Name |
Therapeutic Category |
Pharmacopeial Status |
Standard Pack Size(in Kgs) |
USDMF |
Alendronate Sodium |
Antiosteoporotic |
EP / BP / USP |
5/10/25 |
y |
Amlodipine Besylate |
Cardiovascular |
EP / BP / USP |
5/10/25 |
y |
Atomoxetine Hydrochloride |
Anti-depressant |
In House |
1/5/25 |
y |
Bosentan |
Cardiotonic |
In House |
½/5/10 |
y |
Celecoxib |
Anti-inflammatory |
EP / USP |
5/10/25 |
y |
Chlorhexidine Base |
Disinfectant |
In House |
10/25/50 |
y |
Chlorhexidine Gluconate 20% |
Disinfectant |
EP / BP / USP / JP |
50/200 |
y |
Desloratadine |
Antihistaminic |
In House |
5/10/25 |
y |
Duloxetine hydrochloride |
Anti-depressant |
In House |
2/5/10 |
y |
Ethambutol hydrochloride |
Antituberculous |
EP / BP / USP |
5/10/25 |
y |
Fluoxetine hydrochloride |
Anti-depressant |
EP / BP / USP |
5/10/25 |
y |
Glibenclamide/Glyburide |
Antidiabetic |
EP / BP / USP |
5/10/25 |
y |
Irbesartan |
Antihypertensive |
EP / BP / USP |
5/10/25 |
y |
Itopride Hydrochloride |
Gastroprokinetic |
In House |
5/10/25 |
y |
Loratadine |
Antihistaminic |
EP / BP / USP / JP |
5/10/25 |
y |
Losartan Potassium |
Antihypertensive |
EP / BP / USP |
5/10/25 |
y |
Meloxicam |
Anti-inflammatory |
EP / BP / USP |
5/10/25 |
y |
Nebivolol hydrochloride |
Antihypertensive |
In House |
1/5/10/25 |
y |
Olmesartan Medoxomil |
Antihypertensive |
EP / BP |
5/25 |
y |
Ondansetron Base |
Antiemetic |
USP |
5/25 |
y |
Ondansetron hydrochloride |
Antiemetic |
EP / BP / USP |
1/2/5/10 |
y |
Paliperidone |
Antipsychotic |
In House |
1/2/5 |
y |
Rabeprazole Sodium |
Anti-ulcerative |
In House |
5/10/25 |
y |
Ropinirole Hydrochloride |
Antiparkinson |
In House |
1/5/10/25 |
y |
Rupatadine Fumarate |
Antihistaminic |
In House |
1/2/5/10 |
y |
Sildenafil citrate |
Erectile dysfunction |
EP / USP |
5/10/25 |
y |
Telmisartan |
Antihypertensive |
EP / BP |
5/10/25 |
y |
Valsartan |
Antihypertensive |
EP / BP /USP |
5/10/25 |
y |
Venlafaxine Hydrochloride |
Anti-depressant |
EP / BP / USP |
5/10/25 |
y |
Zolpidem Tartrate |
Sedative-Hypnotic |
EP / BP |
5/10/25 |
y |